Trulicity and Ozempic are medications in the class of drugs called glucagon-like peptide-1s receptor agonists (GLP-1s). These medications mimic the hormone GLP-1 naturally made in the digestive tract to help improve glycemic control, body weight, and type 2 diabetes.
Though both medications are GLP-1s, Trulicity and Ozempic contain different active ingredients: Trulicity contains dulaglutide, while Ozempic contains semaglutide. There are important differences between Trulicity and Ozempic.
Some research suggests that Ozempic (semaglutide) may offer the best weight reduction and reduction in A1C (a measure of blood glucose levels), but that there are lower rates of gastrointestinal side effects with Trulicity and other GLP-1 medications.
What is Trulicity?
Trulicity is a GLP-1 medication that helps treat type 2 diabetes. It is typically injected once weekly in adults. It contains the active compound dulaglutide, and is manufactured by Ely Lilly and Company.
Importantly, Trulicity cannot treat type 1 diabetes or diabetic ketoacidosis.
However, when used as directed, it may decrease the risk of some health complications associated with type 2 diabetes, including heart attack, stroke, kidney failure, nerve damage, eye problems, and gum disease.
Manage weight loss online
See if you’re a good fit for K Health’s online medical weight loss program.
What is Ozempic?
Ozempic is a GLP-1 medication that is also usually injected once weekly for the treatment of type 2 diabetes.
It has also been approved by the FDA to support chronic weight management. It contains the active compound semaglutide, and is manufactured by Novo Nordisk. Ozempic works by helping the pancreas to release the right amount of insulin when blood sugar levels are high.
It also helps to slow the rate of stomach emptying, which can support weight loss.
Trulicity vs. Ozempic
Both Trulicity and Ozempic should be used alongside a comprehensive diet and exercise program in adults. Neither Trulicity nor Ozempic should be used as a quick fix for type 2 diabetes or weight loss.
When taken as directed, both medications can also help to reduce the risk of stroke, heart attack, or death in adults with type 2 diabetes who also have heart and blood vessel disease.
Importantly, Trulicity is only approved for use in adults with type 2 diabetes.
Ozempic is approved for use in people with a body mass index (BMI) of 30 or greater or in people with a BMI of 27 or greater who also have a metabolic health condition, like type 2 diabetes or high blood pressure.
Here’s a summary of the main differences and similarities between the two medications:
Medication class | Active compound | Drug administration | Starting dose | Highest dose available | Gained FDA approval | |
Trulicity | GLP-1 | Dulaglutide | Injection | 0.75 mg/week | 4.5 mg/week | 2014 |
Ozempic | GLP-1 | Semaglutide | Injection | 0.25 mg/week | 1.0 mg/week | 2017 |
Conditions Treated
Both Trulicity and Ozempic have been shown to support weight loss, but only Ozempic is specifically indicated for chronic weight management.
Trulicity
Trulicity is only indicated as an adjunct treatment to diet and exercise to improve glycemic control in adults with type 2 diabetes.
When used regularly, it can decrease the risk of some health complications associated with type 2 diabetes, including heart attack, stroke, kidney failure, nerve damage, eye problems, and gum disease.
Ozempic
Ozempic is also indicated as an adjunct treatment to diet and exercise in adults with type 2 diabetes.
However, it’s also approved for use as a weight loss medication in people with a body mass index (BMI) of 30 or greater who do not have type 2 diabetes.
For people with type 2 diabetes or another metabolic health condition, like high cholesterol or high blood pressure, Ozempic is also approved as long as the patient has a BMI of 27 or higher.
Side Effects
Like most medications, both Trulicity and Ozempic can cause side effects. Most side effects are mild and affect the gastrointestinal system.
According to one review, the rate of side effects is higher with Ozempic than with Trulicity.
Trulicity
The most common side effects of Ozempic are:
Serious side effects are also possible with Trulicity medication. Please seek emergency care if you experience any of the following:
- Vomiting
- Hives
- Rash
- Ongoing pain that starts in the upper or middle of the stomach (but can spread to the back)
- Itching
- Difficulty breathing or swallowing
- Swelling of the lips, tongue, face or throat
- Vision changes
- Fast heartbeat
Ozempic
The most common side effects of Ozempic are:
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Constipation
- Burping
- Heartburn
Serious side effects are rare, but still possible.
If you experience any of the following, please seek emergency treatment:
- Ongoing pain that begins in the upper left or middle of the stomach but may spread to the back, with or without vomiting
- Rash and itching
- Swelling of the eyes, face, mouth, tongue, or throat
- Difficulty breathing or swallowing
- Decreased urination
- Swelling of legs, ankles, or feet
- Vision changes
- Fainting or dizziness
- Pain in upper stomach
- Yellowing of skin or eyes
- Fever
- Clay-colored stools
- Rapid heartbeat
Warnings
Before starting either medication, be sure to tell your provider about any medications, supplements, or vitamins you’re currently taking. It’s also important to disclose any existing medical conditions you may have.
Neither Trulicity nor Ozempic should be combined with any other GLP-1 or weight loss drug.
Trulicity
Individuals with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not take Trulicity, as this may increase the risk of tumors of the thyroid gland.
Ozempic
Like Trulicity, Ozempic should not be used by individuals with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Effectiveness
In general, GLP-1 medications have been researched for over 16 years and have shown consistent results in the reduction of body weight in obese patients with or without diabetes.
Trulicity
The results of six clinical studies showed that treatment with Trulicity in adults with type 2 diabetes resulted in greater reductions in A1C levels when compared with placebo.
In addition to improving glycemic control, Trulicity may help to reduce the risk of a stroke or heart attack.
Manage weight loss online
See if you’re a good fit for K Health’s online medical weight loss program.
Ozempic
Ozempic has been shown to be effective in support of weight loss as well as for the management of type 2 diabetes.
Research suggests that Ozempic may be more effective at supporting weight loss than other GLP-1s; however, the risk of gastrointestinal side effects may also be greater when taking Ozempic compared to other GLP-1 medications.
Another study funded by Ozempic’s manufacturer Novo Nordisk found that the active ingredient in Ozempic (semaglutide) was more effective than the active ingredient in Trulicity (dulaglutide) at improving glycemic control in patients with type 2 diabetes.
Cost
The cost of GLP-1 medications can vary depending on many factors, including your insurance coverage and the rates at your local pharmacy.
Trulicity
The list price of Trulicity, or what you could pay out-of-pocket without insurance or if your insurance doesn’t cover the medication, is $886.46 per month.
However, with coverage, you could pay as little as $25 per month for the medication.
Ozempic
Without insurance, Ozempic can cost over $1,300 per month. With coverage, you may pay as little as $25 per month.
How to Get Trulicity or Ozempic Online
Now you can get Ozempic or Trulicity online using K Health for just $29 per month.
It’s just three easy steps:
- Answer a few simple questions.
- Chat with your provider.
- Get the care you need.
Frequently Asked Questions
K Health has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical associations. We avoid using tertiary references.
-
Dulaglutide Injection. (2020).
https://medlineplus.gov/druginfo/meds/a614047.html -
GLP-1 receptor agonists: an updated review of head-to-head clinical studies. (2021).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953228/ -
How much should I expect to pay for Trulicity? (n.d).
https://www.lillypricinginfo.com/Trulicity -
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes. (2022).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736331/ -
Semaglutide Injection. (2021).
https://medlineplus.gov/druginfo/meds/a618008.html#side-effects -
Semaglutide Shines as Weight Loss Therapy. (2021).
https://www.medpagetoday.com/primarycare/obesity/91146 -
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. (2018).
https://pubmed.ncbi.nlm.nih.gov/29397376/ -
Trulicity (Dulaglutide): A New GLP-1 Receptor Agonist Once-Weekly Subcutaneous Injection Approved for the Treatment of Patients with Type 2 Diabetes. (2015).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665063/ -
Wegovy (semaglutide): a new weight loss drug for chronic weight management. (2022).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717485/